32nd week of 2021 patent applcation highlights part 9 |
Patent application number | Title | Published |
20210244734 | METHODS AND MATERIALS FOR IMPROVING ARTERIOVENOUS FISTULA MATURATION AND MAINTAINING ARTERIOVENOUS FISTULA FUNCTIONALITY | 2021-08-12 |
20210244735 | COMPOSITIONS AND METHODS FOR TREATING MYELOFIBROSIS | 2021-08-12 |
20210244736 | Methods for Treating Cancer Using Pyrimidine and Pyridine Compounds with BTK Inhibitory Activity | 2021-08-12 |
20210244737 | COMPOSITIONS FOR TREATING MELANOMA | 2021-08-12 |
20210244738 | COMPOSITIONS AND METHODS FOR SUPPRESSING NONSENSE MUTATIONS | 2021-08-12 |
20210244739 | Poxvirus Host Range Protein K3 as a Positive Selection Marker for Generation of Recombinant Poxviruses, a Therapeutic Target for Poxvirus Infection and a Therapeutic Agent for PKR Related Diseases | 2021-08-12 |
20210244740 | INHIBITORS OF RSV REPLICATION AND APPLICATIONS THEREOF | 2021-08-12 |
20210244741 | METHODS OF TREATING EYE DISEASES ASSOCIATED WITH INFLAMMATION AND VASCULAR PROLIFERATION | 2021-08-12 |
20210244742 | COMPOSITION COMPRISING A THERAPEUTIC AGENT AND A RESPIRATORY STIMULANT AND METHODS FOR THE USE THEREOF | 2021-08-12 |
20210244743 | ANTI-VIRAL COMPOSITIONS AND METHODS OF USE | 2021-08-12 |
20210244744 | TREATING LIVER DISORDERS | 2021-08-12 |
20210244745 | COMBINATION COMPOSITIONS COMPRISING BISFLUOROALKYL-1,4-BENZODIAZEPINONE COMPOUNDS AND METHODS OF USE THEREOF | 2021-08-12 |
20210244746 | COMPOSITIONS AND METHODS FOR TREATING CORONAVIRUS INFECTIONS | 2021-08-12 |
20210244747 | STEROID HORMONE PHARMACEUTICAL FORMULATIONS | 2021-08-12 |
20210244748 | COMPOSITIONS AND METHODS FOR SUPPRESSING OR REDUCING SYSTEMIC IMMUNE RESPONSE IN A SUBJECT | 2021-08-12 |
20210244749 | DARUNAVIR FORMULATIONS | 2021-08-12 |
20210244750 | COMPOSITION FOR INCREASING PERMEABILITY OF BLOOD-BRAIN BARRIER COMPRISING NITRIC OXIDE DONOR AND USE THEREOF | 2021-08-12 |
20210244751 | METHODS AND COMPOSITIONS FOR PROTECTION OF CELLS AND TISSUES FROM COMPUTED TOMOGRAPHY RADIATION | 2021-08-12 |
20210244752 | PH-RESPONSIVE POLYMER-DRUG CONJUGATES FOR ENHANCED ANTIBACTERIAL EFFICACY | 2021-08-12 |
20210244753 | BIOMARKERS FOR PREDICTING RESPONSIVENESS TO DECITABINE THERAPY | 2021-08-12 |
20210244754 | DEOXYNUCLEOSIDE THERAPY FOR DISEASES CAUSED BY UNBALANCED NUCLEOTIDE POOLS INCLUDING MITOCHONDRIAL DNA DEPLETION SYNDROMES | 2021-08-12 |
20210244755 | METHODS FOR TREATING CANCERS BY PRODRUGS OF CLOFARABINE | 2021-08-12 |
20210244756 | Ozone Foam for Treating Dermatitis | 2021-08-12 |
20210244757 | Pharmaceutical composition for treating cancer comprising metal ion-bound ionic compound | 2021-08-12 |
20210244758 | USE OF PHOSPHORUS-BASED MATERIAL IN PREPARATION OF MEDICAMENT FOR TREATING TUMORS | 2021-08-12 |
20210244759 | UNIVERSAL PLATFORM FOR CAR THERAPY TARGETING A NOVEL ANTIGENIC SIGNATURE OF CANCER | 2021-08-12 |
20210244760 | CHIMERIC ANTIGEN RECEPTOR TUMOR INFILTRATING LYMPHOCYTES | 2021-08-12 |
20210244761 | Administration of Engineered T Cells for Treatment of Cancers in the Central Nervous System | 2021-08-12 |
20210244762 | CAR-T CELLS EXPRESSING AN INHIBITORY ANTI-TGF-BETA-RECEPTOR II SINGLE DOMAIN ANTIBODY | 2021-08-12 |
20210244763 | COMPOSITIONS AND METHODS OF HEMATOPOIETIC STEM CELL TRANSPLANTS | 2021-08-12 |
20210244764 | NOVEL CELLULAR RECEPTORS AND USES THEREOF | 2021-08-12 |
20210244765 | PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS | 2021-08-12 |
20210244766 | TISSUE HEALING AGENT | 2021-08-12 |
20210244767 | PHARMACEUTICAL COMPOSITION FOR DERMATOLOGY AND USES THEREOF | 2021-08-12 |
20210244768 | CELL COMPOSITIONS AND USES THEREOF | 2021-08-12 |
20210244769 | PAIN-REDUCING EFFECTS OF FIBROBLASTS AND TREATMENT OF PAIN | 2021-08-12 |
20210244770 | METHOD FOR XENO-FREE GENERATION OF A POPULATION OF HMPC | 2021-08-12 |
20210244771 | METHODS AND MATERIALS FOR TREATING NERVE INJURIES AND NEUROLOGICAL DISORDERS | 2021-08-12 |
20210244772 | Methods for the Treatment of Autism Spectrum Disorders | 2021-08-12 |
20210244773 | DENTAL PULP STEM CELLS AND USES THEREOF | 2021-08-12 |
20210244774 | COMPOSITIONS AND METHODS | 2021-08-12 |
20210244775 | Composition and Method of Using Germinative Compounds in Probiotics for Inflammation Reduction in Humans | 2021-08-12 |
20210244776 | Microbiome-based informed method to formulate live biotherapeutics | 2021-08-12 |
20210244777 | NOVEL BIFIDOBACTERIUM BACTERIA AND COMPOSITION INCLUDING NOVEL BIFIDOBACTERIUM BACTERIA | 2021-08-12 |
20210244778 | BIFIDOBACTERIA FOR REDUCING FOOD, ENERGY AND/OR FAT INTAKE | 2021-08-12 |
20210244779 | COMPOSITIONS AND USES THEREOF | 2021-08-12 |
20210244780 | AGENTS FOR MODULATING THE EXPRESSION OF HEAT SHOCK PROTEINS AND RELATED METHODS | 2021-08-12 |
20210244781 | SUPERABSORBENT MATERIALS AND METHODS OF MAKING THE SAME | 2021-08-12 |
20210244782 | COMPOSITIONS COMPRISING AN AMERICAN CRANBERRY EXTRACT AND PHOSPHOLIPIDS | 2021-08-12 |
20210244783 | COMPOSITION COMPRISING CLEMATIS MANDSHURICA EXTRACT AS ACTIVE INGREDIENT FOR COGNITIVE FUNCTION IMPROVEMENT | 2021-08-12 |
20210244784 | COMPOSITION, AND METHOD OF USING THE COMPOSITION, EFFECTIVE FOR MINIMIZING THE HARMFUL EFFECTS ASSOCIATE WITH INDIVIDUALS SUFFERING FROM ALCOHOL INTOXICATION | 2021-08-12 |
20210244785 | COMPOSITIONS AND METHODS FOR THE ANTISEPTIC TREATMENT OF BIOFILMS ON MAMMALIAN TISSUE | 2021-08-12 |
20210244786 | COMPOSITIONS AND METHODS FOR NUTRITIONAL SUPPLEMENTS | 2021-08-12 |
20210244787 | Nutritional Supplements Containing A Peptide Component And Uses Thereof | 2021-08-12 |
20210244788 | ORAL PEPTIDE ANTAGONISTS OF MULTIPLE CHEMOKINE RECEPTORS FOR REVERSING LOSS OF SYNAPSES AND DENDRITIC SPINES | 2021-08-12 |
20210244789 | COMPOSITIONS AND METHODS FOR TREATMENT OF INTRACELLULAR DAMAGE AND BACTERIAL INFECTION | 2021-08-12 |
20210244790 | ENHANCEMENT OF ANTIBACTERIAL ACTIONS OF A DEPSIPEPTIDE ANTIBIOTIC USING SYNERGISTIC AMOUNTS OF BORIC ACID | 2021-08-12 |
20210244791 | APPLICATION OF PEDF-DERIVED SHORT PEPTIDES IN TENDON HEALING | 2021-08-12 |
20210244792 | Method of Treating Respiratory Disorders | 2021-08-12 |
20210244793 | NOVEL AIMP1 PROTEIN FRAGMENT AND HAIR GROWTH-PROMOTING COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT | 2021-08-12 |
20210244794 | Stem Cell Stimulating Compositions for Treatment of Melasma | 2021-08-12 |
20210244795 | COMPOSITIONS AND METHODS FOR IN VIVO POST TRANSLATIONAL MODIFICATION | 2021-08-12 |
20210244796 | COMPOSITIONS IN THE FORM OF AN INJECTABLE AQUEOUS SOLUTION COMPRISING AMYLIN AN AMYLIN RECEPTOR AGONIST OR AN AMYLIN ANALOG, AT LEAST ONE IONIC SPECIES AND AN AMPHOIPHILIC COMPOUNDS CONTAINING HYDRIPHOBIC RADICALS | 2021-08-12 |
20210244797 | ENHANCING CHEMOTHERAPY IN MEDULLOBLASTOMA AND GLIOBLASTOMA WITH HIGH BASAL p53 LEVELS | 2021-08-12 |
20210244798 | ACYLATED GLP-1/GLP-2 DUAL AGONISTS | 2021-08-12 |
20210244799 | USES OF GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS FOR TREATING TRAUMA-INDUCED HEARING LOSS | 2021-08-12 |
20210244800 | Use of Ultrarapid Acting Insulin | 2021-08-12 |
20210244801 | Enzymes Entrapped in Organopolysiloxane Matrix for Treating Intestinal Diseases | 2021-08-12 |
20210244802 | Endolysins Active Against Bacillus Bacteria, Pharmaceutical Compositions, and Methods Relating Thereto | 2021-08-12 |
20210244803 | COMPOSITIONS AND METHODS FOR TREATING POMPE DISEASE | 2021-08-12 |
20210244804 | HUMAN ALPHA-GALACTOSIDASE VARIANTS | 2021-08-12 |
20210244805 | PHARMACEUTICAL FOR PREVENTION OF BLEOMYCIN-INDUCED PULMONARY FIBROSIS | 2021-08-12 |
20210244806 | Recombinant Protease Inhibitor-Containing Compositions, Methods for Producing Same and Uses Thereof | 2021-08-12 |
20210244807 | MYCOPLASMA VACCINES AND USES THEREOF | 2021-08-12 |
20210244808 | METHODS FOR INHIBITING BIOFILM FORMATION | 2021-08-12 |
20210244809 | DEVELOPMENT OF A NOVEL LIVE ATTENUATED AFRICAN SWINE FEVER VACCINE BASED IN THE DELETION OF GENE I177L | 2021-08-12 |
20210244810 | RECOMBINANT H7N9 SUBTYPE AVIAN INFLUENZA VIRUS, INACTIVATED MARKED VACCINE AND PREPARATION METHOD THEREOF | 2021-08-12 |
20210244811 | COMPOSITIONS IMMUNOGENIC AGAINST SARS CORONAVIRUS 2, METHODS OF MAKING, AND USING THEREOF | 2021-08-12 |
20210244812 | COMPOSITIONS AND METHODS CONCERNING IMMUNE TOLERANCE | 2021-08-12 |
20210244813 | ADJUVANT AND VACCINE COMPOSITIONS | 2021-08-12 |
20210244814 | COMBINATION OF METFORMIN AND CYCLOPHOSPHAMIDE AS AN ADJUVANT IN CANCER IMMUNOTHERAPY | 2021-08-12 |
20210244815 | ANTI-CD3 ANTIBODIES AND METHODS OF USE | 2021-08-12 |
20210244816 | CD47 BLOCKADE WITH RADIATION THERAPY | 2021-08-12 |
20210244817 | INJECTABLE SLURRIES AND METHODS OF MANUFACTURING AND USING THE SAME | 2021-08-12 |
20210244818 | Naltrexone Long Acting Formulations and Methods of Use | 2021-08-12 |
20210244819 | SESAME OIL BASED INJECTION FORMULATIONS | 2021-08-12 |
20210244820 | PHARMACEUTICAL COMPOSITIONS COMPRISING POH DERIVATIVES | 2021-08-12 |
20210244821 | CHO CELL EXPRESSED HET IL-15 | 2021-08-12 |
20210244822 | CONJUGATES WITH INTERNAL AND TERMINAL-END HEPAROSAN LINKAGES | 2021-08-12 |
20210244823 | TARGETING M2-LIKE TUMOR-ASSOCIATED MACROPHAGES BY USING MELITTIN-BASED PROAPOPTOTIC PEPTIDE | 2021-08-12 |
20210244824 | POLYPEPTIDE CONJUGATES FOR INTRACELLULAR DELIVERY OF NUCLEIC ACIDS | 2021-08-12 |
20210244825 | IL-21 ANTIBODIES | 2021-08-12 |
20210244826 | SHORT INTERFERING RNA TEMPLATED LIPOPROTEIN PARTICLES (SIRNA-TLP) | 2021-08-12 |
20210244827 | ANC80 ENCODING SPHINGOLIPID-METABOLIZING PROTEINS | 2021-08-12 |
20210244828 | MIRI26-5P FOR TREATING MOTOR NEURON DISEASES | 2021-08-12 |
20210244829 | FLUORESCENCE COLORING FOR EYE SURGERY | 2021-08-12 |
20210244830 | TMEM-MCD IN THE MINIMALLY INVASIVE ASSESSMENT OF THE ACTIVITY STATUS OF TMEM IN ITS DISSEMINATION OF TUMOR CELLS | 2021-08-12 |
20210244831 | POLYDOPAMINE DECORATED TOBACCO MOSAIC THERANOSTIC VIRUS NANOPARTICLES | 2021-08-12 |
20210244832 | BIO-IMAGING PROBES AND METHODS FOR NON-INVASIVE DETECTION OF HUMAN UTERINE SARCOMAS | 2021-08-12 |
20210244833 | ULTRAVIOLET LIGHT TREATMENT CHAMBER | 2021-08-12 |